Health Sciences Acquisitions Corp. 2 (HSAQ) Prices Upsized $139.1M IPO

Health Sciences Acquisitions Corp. 2 (HSAQ), announced the pricing of their upsized $139.1 million SPAC IPO this morning and the shares are expected to begin trading today, Tuesday, August 4th, under the symbol Nasdaq: HSAQ.

Health Sciences 2 intends to focus on businesses in the biopharma and medical technology sectors and will be led by Roderick Wong MD, as President, CEO and Chairman, and CFO Naveen Yalamanchi, MD.

Total SPAC deal count for 2020 year-to-date is now 56 with $22.7 billion in gross proceeds raised. The offering is anticipated to close on Thursday, August 6, 2020.

Chardan and Barclays are acting as joint book-running managers of the offering. Loeb & Loeb LLP and Kirkland & Ellis LLP were Issuer’s Counsel and Underwriter’s Counsel, respectively. WithumSmith+Brown, PC, acted as auditor.